Shire Pharmaceuticals Group Plc
Shire's Clear and Focused Strategy Delivers Record Quarterly Revenues. Non GAAP Diluted Earnings per ADS up 60%
Dublin (ots/PRNewswire) - - Increases Non GAAP diluted earnings per ADS growth guidance to the high thirty percent range for the full year (2014). Shire announces unaudited results for the three months to September 30, 2014. Financial Highlights Q3 2014 Growth[1] $1,552 Product sales million +33%[2] $1,597 Total ...